Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
DBV Technologies ADR (NASDAQ: DBVT) closed the day trading at $19.03 up 0.58% from the previous closing price of $18.92. In other words, the price has increased by $0.58 from its previous closing price. On the day, 0.15 million shares were traded. DBVT stock price reached its highest trading level at $19.1899 during the session, while it also had its lowest trading level at $18.6127.
Ratios:
For a better understanding of DBVT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In the most recent recommendation for this company, Cantor Fitzgerald on December 15, 2025, initiated with a Overweight rating and assigned the stock a target price of $42.
On December 03, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $35.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 17 ’25 when EPIC Bpifrance sold 2,076,990 shares for $4.85 per share. The transaction valued at 10,070,232 led to the insider holds 8,595,472 shares of the business.
EPIC Bpifrance sold 1,292,103 shares of DBVT for $5,413,912 on Dec 18 ’25. The Member of 10% owner group now owns 7,303,369 shares after completing the transaction at $4.19 per share. On Nov 20 ’25, another insider, Mohideen Pharis, who serves as the Chief Medical Officer of the company, sold 6,496 shares for $2.88 each. As a result, the insider received 18,708 and left with 103,153 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DBVT now has a Market Capitalization of 763741952 and an Enterprise Value of 3153048064. Its current Enterprise Value per Revenue stands at 573.073.
Stock Price History:
The Beta on a monthly basis for DBVT is -1.13, which has changed by 5.3489933 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, DBVT has reached a high of $26.18, while it has fallen to a 52-week low of $2.92. The 50-Day Moving Average of the stock is 21.77%, while the 200-Day Moving Average is calculated to be 75.98%.
Shares Statistics:
Over the past 3-months, DBVT traded about 353.07K shares per day on average, while over the past 10 days, DBVT traded about 941460 shares per day. A total of 40.14M shares are outstanding, with a floating share count of 32.94M. Insiders hold about 17.94% of the company’s shares, while institutions hold 33.81% stake in the company. Shares short for DBVT as of 1764288000 were 32231 with a Short Ratio of 0.47, compared to 1761868800 on 21715. Therefore, it implies a Short% of Shares Outstanding of 32231 and a Short% of Float of 0.1.
Earnings Estimates
At present, 4.0 analysts are actively evaluating the performance of DBV Technologies ADR (DBVT) in the stock market.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.06 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.67 and -$0.93 for the fiscal current year, implying an average EPS of -$0.86. EPS for the following year is -$0.46, with 4.0 analysts recommending between -$0.25 and -$0.95.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for DBVT’s current fiscal year. The highest revenue estimate was $6.71M, while the lowest revenue estimate was $4.25M, resulting in an average revenue estimate of $5.33M. In the same quarter a year ago, actual revenue was $3.88M
